IPSASB unveils the world's first dedicated climate reporting standard for governments and public bodies, mandating disclosures from 2028 to illuminate financial risks and opportunities.
Afya Ltd., a leading medical education group in Brazil, is demonstrating robust financial health with a rising Return on Capital Employed (ROCE) and significant capital expansion. While its stock has faced headwinds, the underlying operational metrics suggest a company efficiently reinvesting for growth, presenting a potential opportunity for value-focused investors.
A hefty cash reserve is typically a corporate strength, but for some companies, it signals stagnation rather than security. We examine three firms—Box, C3.ai, and Novavax—where significant net cash positions fail to offset concerns over growth prospects and valuation.
While small-cap stocks offer potential for high returns ahead of Wall Street coverage, their lack of scale compared to larger rivals introduces significant risk. We analyze one contender with strong prospects and two that may disappoint.
A new financial analysis suggests shares of the documentary-focused streaming service CuriosityStream may be trading significantly below their estimated intrinsic value, presenting a potential opportunity for investors.
While Vidhance (FRA:8W50) continues to operate at a loss, its current cash reserves and manageable burn rate suggest the company has time to execute its growth strategy. However, a recent dip in revenue adds a note of caution for investors.
Following a significant pullback, NetEase (SEHK: 9999) shares are trading at levels that some analysts deem undervalued. We examine the financial models, peer comparisons, and the broader sector headwinds facing the Chinese gaming giant to assess if the current price presents a strategic entry point for long-term investors.
As Hot Chili Ltd (ASX:HCH) advances its La Verde copper-gold project and completes a A$40.1 million capital raise, investors are weighing its recent stellar share price performance against a valuation that remains at a discount to sector peers. The company's momentum highlights both the potential of its Chilean assets and the persistent risks of early-stage resource development.
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
Eastern Bankshares (EBC) concludes a transformative year, reporting full-year 2025 results, affirming its dividend, and completing a share repurchase. The moves have propelled its stock, raising questions about its valuation amidst a shifting banking landscape.
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
While Tesla's stock remains resilient, the promise of a self-driving future presents both staggering potential and significant hurdles for investors to consider.
GXO Logistics has unveiled a series of leadership changes, including the appointment of a new Chief Operating Officer and an interim Chief Accounting Officer, as the company sharpens its focus on operational execution and financial reporting quality amid intense industry competition.
Shares of Empire State Realty Trust (ESRT) are trading at $6.63, presenting investors with a conundrum: a narrative suggesting undervaluation clashes with a premium price-to-earnings multiple. We examine the divergence and what it means for the iconic property owner.
VEON is deepening its investment in Uzbekistan's digital economy with a new network operations center for Beeline and the launch of BuildX, a software and AI development unit. The moves signal a strategic pivot from traditional telecom services towards higher-margin digital offerings in Central Asia.
Ondas Holdings advances its defense sector ambitions as its Optimus drone gains Blue List status for expedited U.S. procurement, while formally launching its defense and security division at the Singapore Airshow. The strategic moves come as the company's stock, after significant long-term gains, faces recent pressure, testing investor patience for tangible contract wins.
A deep-dive valuation analysis using a two-stage discounted cash flow model suggests Cadence's current share price may be trading at a premium to its intrinsic value, raising questions for investors in the critical EDA sector.
With a staggering 88% of its shares held by institutions, Kemper Corporation's stock trajectory is deeply influenced by major fund managers. While such ownership often signals credibility, it also introduces unique risks for the property and casualty insurer.
With the annual ISA allowance set to shrink for many in 2027, finding the best tax-free cash savings rate is more crucial than ever. We break down the top deals and what the changes mean for your money.
Vice President Sara Duterte faces renewed impeachment efforts in the Philippine Congress, centered on allegations of misusing millions in confidential funds. The move reignites political tensions in a nation grappling with the legacies of powerful political dynasties.
